Literature DB >> 25638223

ACT and Recovery: What We Know About Their Compatibility.

Gary Morse1, Ashley M H Glass2, Maria Monroe-DeVita3.   

Abstract

While assertive community treatment (ACT) is a widely implemented evidence-based practice, the extent of its recovery orientation has been debated. A literature search identified 16 empirical articles studying recovery and ACT. These 16 studies were classified as involving stakeholder perceptions, interventions, or fidelity measurement. Stakeholders generally viewed ACT as being recovery oriented; research on both interventions and fidelity measurement showed promising approaches. Overall the literature yielded encouraging findings regarding ACT and recovery, though there remains a dearth of research on the topic. We discuss future directions for research and practice to ensure that ACT programs skillfully support recovery.

Keywords:  ACT; Fidelity; Person-centered; Recovery orientation

Mesh:

Year:  2016        PMID: 25638223     DOI: 10.1007/s10488-015-0631-3

Source DB:  PubMed          Journal:  Adm Policy Ment Health        ISSN: 0894-587X


  4 in total

1.  Implementing illness management and recovery within assertive community treatment teams: A qualitative study.

Authors:  Gary Morse; Maria Monroe-DeVita; Mary M York; Roselyn Peterson; Joris Miller; MacKenzie Hughes; Elizabeth Carpenter-Song; Christopher Akiba; Gregory J McHugo
Journal:  Psychiatr Rehabil J       Date:  2019-09-02

2.  Recovery Services and Outcomes in a State Psychiatric Hospital.

Authors:  Bei-Hung Chang; Jeffrey L Geller; Kathleen Biebel
Journal:  Psychiatr Q       Date:  2018-09

3.  Transitions from Assertive Community Treatment Among Urban and Rural Teams: Identifying Barriers, Service Options, and Strategies.

Authors:  Andrea M LeFebvre; Bill Dare; Susan J Farrell; Gary S Cuddeback
Journal:  Community Ment Health J       Date:  2017-09-01

4.  Innovation and Its Discontents: Pathways and Barriers in the Diffusion of Assertive Community Treatment.

Authors:  David A Rochefort
Journal:  Milbank Q       Date:  2019-11-04       Impact factor: 4.911

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.